Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep342 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor-γ mutation, H449L

Demir Tevfik , Onay Huseyin , Savage David B , Kuruuzum Ayse Kubat , Erdeve Senay Savas , Altay Canan , Ozen Samim , Demir Leyla , Cavdar Umit , Akinci Baris

Introduction: Familial partial lipodystrophy (FPL) is a rare genetic disorder characterised by a selective lack of subcutaneous fat that is associated with insulin resistance and diabetes. FPL has been reported to be caused by mutations in the peroxisome proliferator activator receptor-γ (PPARG) gene, which encodes a key transcription factor that regulates adipocyte differentiation and insulin sensitivity.Material and methods: The objective of this ...

ea0037ep345 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Acquired partial lipodystrophy is associated with increased risk for metabolic complications

Akinci Baris , Koseoglu Fatos , Onay Huseyin , Yavuz Sevgi , Altay Canan , Simsir Ilgin Yildirim , Ozisik Secil , Demir Leyla , Korkut Meltem , Yilmaz Nusret , Ozen Samim , Akinci Gulcin , Atik Tahir , Calan Mehmet , Secil Mustafa , Comlekci Abdurrahman , Demir Tevfik

Objective: Acquired partial lipodystrophy (APL) is a rare disorder characterized by progressive selective fat loss. In previous studies, metabolic complications were reported to be relatively rare in APL, while they were quite common in other types of lipodystrophy syndromes. However, so far, there has been no systematic study on metabolic complications in APL.Methods: We have systematically evaluated 21 APL patients in the Turkish Lipodystrophy Study Gr...